| Literature DB >> 29320464 |
Frederik Tilmann von Rosen1,2, Antonella Juline von Rosen3,4, Falk Müller-Riemenschneider5,6, Inken Damberg7, Peter Tinnemann8,9.
Abstract
Sexually transmitted infections (STIs) pose a significant threat to individual and public health. They disproportionately affect adolescents and young adults. In a cross-sectional study, we assessed self-rated and factual STI knowledge in a sample of 9th graders in 13 secondary schools in Berlin, Germany. Differences by age, gender, migrant background, and school type were quantified using bivariate and multivariable analyses. A total of 1177 students in 61 classes participated. The mean age was 14.6 (SD = 0.7), 47.5% were female, and 52.9% had at least one immigrant parent. Knowledge of human immunodeficiency virus (HIV) was widespread, but other STIs were less known. For example, 46.2% had never heard of chlamydia, 10.8% knew of the HPV vaccination, and only 2.2% were aware that no cure exists for HPV infection. While boys were more likely to describe their knowledge as good, there was no general gender superiority in factual knowledge. Children of immigrants and students in the least academic schools had lower knowledge overall. Our results show that despite their particular risk to contract an STI, adolescents suffer from suboptimal levels of knowledge on STIs beyond HIV. Urgent efforts needed to improve adolescent STI knowledge in order to improve the uptake of primary and secondary prevention.Entities:
Keywords: Berlin; Germany; adolescent health; sexual health; sexually transmitted diseases; sexually transmitted infections
Mesh:
Year: 2018 PMID: 29320464 PMCID: PMC5800209 DOI: 10.3390/ijerph15010110
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Self-rated knowledge of sexually transmitted infections (STIs) in order of decreasing awareness.
| Self-Rated Knowledge | ||||||
|---|---|---|---|---|---|---|
| STI | Good n (%) | Rather Good n (%) | Mediocre n (%) | Rather Bad n (%) | Bad n (%) | Never Heard n (%) |
| HIV | 438 (38.2%) | 379 (33.0%) | 217 (18.9%) | 58 (5.1%) | 39 (3.4%) | 17 (1.5%) |
| Hepatitis B | 142 (12.5%) | 170 (15.0%) | 292 (25.7%) | 231 (20.3%) | 150 (13.2%) | 151 (13.3%) |
| Genital herpes | 109 (9.7%) | 129 (11.4%) | 264 (23.4%) | 219 (19.4%) | 143 (12.7%) | 266 (23.5%) |
| Syphilis | 80 (7.1%) | 129 (11.4%) | 238 (21.0%) | 188 (16.6%) | 116 (10.3%) | 380 (33.6%) |
| HPV | 66 (5.9%) | 82 (7.3%) | 163 (14.4%) | 218 (19.3%) | 178 (15.8%) | 422 (37.4%) |
| Gonorrhoea | 84 (7.5%) | 76 (6.8%) | 170 (15.1%) | 173 (15.4%) | 141 (12.5%) | 481 (42.8%) |
| Chlamydia | 63 (5.6%) | 71 (6.3%) | 154 (13.6%) | 174 (15.3%) | 148 (13.1%) | 6.2%) |
* number of responses included.
Self-rated knowledge by gender.
| Self-Rated Knowledge | ||||||||
|---|---|---|---|---|---|---|---|---|
| STI | Gender | Good | Rather Good | Mediocre | Rather Bad | Bad | Never Heard | |
| HIV | female | 32.0% | 35.1% | 22.6% | 5.5% | 3.9% | 0.9% | 0.001 |
| n = 1134 * | male | 43.3% | 31.0% | 15.9% | 4.7% | 3.0% | 2.0% | |
| Hepatitis B | female | 11.3% | 15.6% | 25.6% | 21.2% | 13.2% | 13.2% | 0.96 |
| n = 1122 * | male | 12.9% | 14.6% | 25.9% | 20.0% | 13.2% | 13.4% | |
| Genital herpes | female | 6.8% | 9.7% | 23.7% | 20.6% | 13.1% | 26.1% | 0.03 |
| n = 1116 * | male | 11.4% | 13.1% | 23.1% | 18.5% | 12.2% | 21.6% | |
| Syphilis | female | 5.1% | 8.1% | 19.4% | 16.0% | 11.1% | 40.3% | <0.001 |
| n = 1117 * | male | 8.2% | 14.3% | 22.7% | 17.4% | 9.2% | 28.2% | |
| HPV | female | 3.8% | 5.3% | 14.0% | 19.8% | 15.5% | 41.6% | 0.01 |
| n = 1116 * | male | 7.2% | 9.2% | 14.8% | 19.1% | 15.8% | 33.9% | |
| Gonorrhoea | female | 4.2% | 6.2% | 12.5% | 15.7% | 13.4% | 48.0% | <0.001 |
| n = 1112 * | male | 9.6% | 7.4% | 17.5% | 15.4% | 11.7% | 38.4% | |
| Chlamydia | female | 5.8% | 6.2% | 11.6% | 17.1% | 13.1% | 46.2% | 0.45 |
| n = 1121 * | male | 4.8% | 6.5% | 15.1% | 14.1% | 12.9% | 46.6% |
* number of responses included.
Factors associated with high self-evaluated knowledge in multivariable analysis.
| Age (per year increase) | 1.00 (0.83–1.19) | 1.12 (0.89–1.41) | 1.23 (0.92–1.66) | 1.20 (0.83–1.74) |
| Female Gender * | 0.71 (0.52–0.97) *** | 1.03 (0.73–1.45) | 0.65 (0.51–0.82) *** | 0.55 (0.4–0.75) *** |
| Migratory Background * | 0.58 (0.45–0.74) *** | 0.96 (0.75–1.23) | 1.04 (0.71–1.51) | 0.69 (0.49–0.97) *** |
| Intermediate School Tier * | 1.51 (0.72–3.17) | 0.92 (0.76–1.10) | 1.62 (0.59–4.43) | 1.30 (0.66–2.55) |
| Highest School Tier * | 1.13 (0.51–2.50) | 0.66 (0.44–0.98) *** | 0.66 (0.25–1.74) | 1.19 (0.59–2.40) |
| Age (per year increase) | 1.20 (0.87–1.65) | 1.41 (1.07–1.86) *** | 0.97 (0.72–1.32) | |
| Female Gender * | 0.56 (0.40–0.78) *** | 0.65 (0.43–0.99) *** | 1.15 (0.69–1.91) | |
| Migratory Background * | 1.05 (0.78–1.43) | 0.77 (0.5–1.21) | 0.89 (0.57–1.39) | |
| Intermediate School Tier * | 1.12 (0.54–2.33) | 0.69 (0.33–1.43) | 1.09 (0.60–1.99) | |
| Highest School Tier * | 0.44 (0.22–0.88) *** | 0.58 (0.28–1.21) | 0.44 (0.23–0.82) *** |
OR: Odds ratio; CI: Confidence interval; * Reference categories are male gender, no migrant background, and lowest school tier. ** number of participants included in the regression model; *** p < 0.05.
Factors associated with unawareness of STIs in multivariable analysis.
| Age (per year increase) | 0.96 (0.70–1.32) | 0.92 (0.66–1.28) | 0.86 (0.67–1.11) | 0.87 (0.68–1.11) |
| Female Gender * | 0.88 (0.65–1.19) | 1.00 (0.61–1.65) | 1.27 (0.85–1.92) | 1.74 (1.37–2.22) *** |
| Migratory Background * | 1.34 (0.96–1.88) | 1.48 (0.87–2.51) | 1.95 (1.52–2.49) *** | 1.70 (1.08–2.67) *** |
| Intermediate School Tier * | 0.61 (0.34–1.08) | 0.81 (0.30–2.19) | 0.47 (0.19–1.19) | 0.63 (0.39–1.01) |
| Highest School Tier * | 0.66 (0.36–1.24) | 1.08 (0.48–2.42) | 0.97 (0.42–2.24) | 0.91 (0.52–1.56) |
| Age (per year increase) | 0.95 (0.78–1.16) | 0.77 (0.60–0.997) *** | 0.85 (0.66–1.10) | |
| Female Gender * | 1.29 (1.01–1.66) *** | 1.39 (1.02–1.91) *** | 0.92 (0.66–1.28) | |
| Migratory Background * | 1.4 (0.94–2.09) | 1.49 (0.98–2.26) | 1.44 (0.94–2.20) | |
| Intermediate School Tier * | 0.83 (0.38–1.85) | 1.11 (0.49–2.47) | 0.73 (0.44–1.18) | |
| Highest School Tier * | 1.78 (0.78–4.08) | 1.33 (0.64–2.78) | 1.33 (0.83–2.11) |
OR: Odds ratio; CI: Confidence interval; * Reference categories are male gender, no migrant background, and lowest school tier. ** number of participants included in the regression model; *** p < 0.05.
Correct answers on STI cures and vaccinations.
| Question | Correct Response | n (%) Correct |
|---|---|---|
| HIV cure (n = 1131 *) | no reliable cure | 946 (83.6%) |
| Hepatitis B cure (n = 1122 *) | no reliable cure | 245 (21.8%) |
| Genital herpes cure (n = 1121 *) | no reliable cure | 88 (7.9%) |
| HPV cure (n = 1126 *) | no reliable cure | 25 (2.2%) |
| Chlamydia cure (n = 1125 *) | cure exists | 212 (18.8%) |
| HIV vaccination (n = 1133 *) | no vaccination | 716 (63.2%) |
| Hepatitis B vaccination (n = 1134 *) | vaccination exists | 552 (48.7%) |
| Genital herpes vaccination (n = 1125 *) | no vaccination | 200 (17.8%) |
| HPV vaccination (n = 1133 *) | vaccination exists | 122 (10.8%) |
| Chlamydia vaccination (n = 1130 *) | no vaccination | 113 (10.0%) |
* number of responses included.
Correct answers on STI cures and vaccinations by gender.
| Question | Gender | Percentage Correct | |
|---|---|---|---|
| HIV cure | male | 82.5% | 0.29 |
| n = 1116 * | female | 85.0% | |
| Hepatitis B cure | male | 24.4% | 0.03 |
| n = 1108 * | female | 19.0% | |
| Genital herpes cure | male | 11.0% | <0.001 |
| n = 1107 * | female | 4.2% | |
| HPV cure | male | 2.6% | 0.41 |
| n = 1113 * | female | 1.7% | |
| Chlamydia cure | male | 18.3% | 0.76 |
| n = 1112 * | female | 19.1% | |
| HIV vaccination | male | 66.8% | 0.02 |
| n = 1119 * | female | 59.8% | |
| Hepatitis B vaccination | male | 45.5% | 0.02 |
| n = 1120 * | female | 52.4% | |
| Genital herpes vaccination | male | 17.4% | 0.70 |
| n = 1111 * | female | 18.3% | |
| HPV vaccination | male | 12.9% | 0.01 |
| n = 1119 * | female | 7.9% | |
| Chlamydia vaccination | male | 8.8% | 0.23 |
| n = 1116 * | female | 11.0% |
* number of responses included.
Factors associated with correct responses on cure and vaccination questions.
| Age (per year increase) | 1.00 (0.82–1.22) | 1.23 (0.94–1.61) | 1.14 (0.90–1.45) | 1.02 (0.86–1.22) | 1.29 (1.08–1.54) ** |
| Female Gender * | 1.14 (0.82–1.58) | 0.93 (0.71–1.22) | 0.37 (0.22–0.61) ** | 0.91 (0.68–1.21) | 1.13 (0.83–1.52) |
| Migratory Background * | 0.73 (0.47–1.12) | 0.82 (0.53–1.28) | 1.22 (0.82–1.81) | 1.50 (1.06–2.12) ** | 0.86 (0.65–1.14) |
| Intermediate School Tier * | 3.14 (1.56–6.29) ** | 1.55 (1.02–2.34) ** | 1.89 (0.79–4.55) | 0.98 (0.55–1.77) | 1.62 (1.16–2.26) ** |
| Highest School Tier * | 2.32 (1.11–4.84) ** | 1.43 (0.88–2.32) | 0.41 (0.13–1.29) | 0.83 (0.57–1.22) | 1.05 (0.60–1.83) |
| Age (per year increase) | 1.10 (0.98–1.25) | 1.07 (0.89–1.27) | 1.13 (0.86–1.49) | 1.29 (0.93–1.79) | 1.14 (0.88–1.47) |
| Female Gender * | 0.70 (0.47–1.04) | 1.30 (0.99–1.70) | 1.09 (0.80–1.47) | 0.60 (0.41–0.88) ** | 1.24 (0.94–1.64) |
| Migratory Background * | 0.61 (0.43–0.88) ** | 0.82 (0.69–0.98) | 0.75 (0.53–1.07) | 0.74 (0.45–1.23) | 0.71 (0.47–1.07) |
| Intermediate School Tier * | 2.59 (1.71–3.94) ** | 1.31 (0.83–2.07) | 1.61 (0.79–3.29) | 1.77 (1.10–2.87) ** | 1.88 (1.34–2.63) ** |
| Highest School Tier * | 1.70 (1.01–2.86) ** | 1.14 (0.77–1.68) | 1.12 (0.43–2.92) | 0.65 (0.29–1.46) | 1.12 (0.72–1.73) |
OR: Odds ratio; CI: Confidence interval; * number of participants included in the regression model; ** p < 0.05.